| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 127751-08-0 | Tetrakis(2-propynyloxymethyl) methane | C17H20O4 |
| 127753-52-0 | 3'-Azido-3'-deoxythymidine 5'-(tetrahydrogen triphosphate) compd. with N,N-diethylethanamine (1:3) | C10H16N5O13P3.3(C6H15N) |
| 127759-89-1 | Lobucavir | C11H15N5O3 |
| 127779-20-8 | Saquinavir | C38H50N6O5 |
| 127780-16-9 | Pantoprazole sulfone | C16H15F2N3O5S |
| 127785-96-0 | 6-Aminomethyl-6,11-dihydro-5H-dibenz[b,e]azepine (E)-2-butenedioate | C15H16N2.C4H4O4 |
| 127786-29-2 | Epinastine hydrobromide | C16H15N3.HBr |
| 127791-54-2 | (2E)-3-(3,5-Dihydroxyphenyl)-2-propenoic acid | C9H8O4 |
| 127792-23-8 | 2-[(2-Bromo-6-chlorophenyl)amino]benzeneacetic acid | C14H11BrClNO2 |
| 127792-49-8 | 2-Bromo-5-chlorobenzeneacetonitrile | C8H5BrClN |
| 127799-54-6 | 2-Methylhydrazinecarboxylic acid tert-butyl ester | C6H14N2O2 |
| 127817-85-0 | 4-Methoxy-2-(trifluoromethyl)benzoic acid | C9H7F3O3 |
| 127818-58-0 | 3-Methyl-5-nitrophenol | C7H7NO3 |
| 127827-52-5 | 6-Bromo-7-fluoroquinoline | C9H5BrFN |
| 127827-54-7 | 6-Bromo-7-chloroquinoline | C9H5BrClN |
| 127828-22-2 | tert-Butyl [2-(2-aminoethoxy)ethyl]carbamate | C9H20N2O3 |
| 127830-16-4 | Acid Brown 402 | |
| 127842-54-0 | 3,4-Bis(difluoromethoxy)benzaldehyde | C9H6F4O3 |
| 127852-21-5 | (S)-1-[3-(Trifluoromethyl)phenyl]ethylamine | C9H10F3N |
| 127852-22-6 | (S)-1-(3-Cyanophenyl)ethylamine | C9H10N2 |
| 127852-24-8 | (+)-(R)-1-(3-Trifluoromethylphenyl)ethanol | C9H9F3O |
| 127852-27-1 | (S)-1-[(2-Trifluoromethyl)phenyl]ethanol | C9H9F3O |
| 127852-28-2 | (R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol | C10H8F6O |
| 127852-29-3 | (R)-1-[2-(Trifluoromethyl)phenyl]ethanol | C9H9F3O |
| 127852-30-6 | (R)-1-[3-(Trifluoromethyl)phenyl]ethylamine | C9H10F3N |
| 127852-31-7 | (R)-3-(1-Aminoethyl)benzonitrile | C9H10N2 |
| 127862-89-9 | (alphaS)-alpha-[[(Phenylmethoxy)carbonyl]amino]benzenebutanoic acid | C18H19NO4 |
| 127869-51-6 | Human C-type natriuretic peptide(1-22) | C93H157N27O28S3 |
| 127892-62-0 | 4-Chloro-3-ethyl-1-methyl-1H-pyrazole-5-carboxylic acid | C7H9ClN2O2 |
| 127910-31-0 | (3E)-2-Amino-4-methyl-5-phosphono-3-pentenoic acid | C6H12NO5P |
| 127912-48-5 | (7R)-4-Hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxododecyl)oxy]methyl]-3,5,8-trioxa-4-phosphahexacosan-1-aminium inner salt 4-oxide | C38H76NO8P |
| 127913-44-4 | (S)-4-Chloro-3-hydroxybutyronitrile | C4H6ClNO |
| 127919-26-0 | 5-(2-Chlorophenyl)-4-oxazolecarboxylic acid ethyl ester | C12H10ClNO3 |
| 127919-27-1 | 5-(3-Chlorophenyl)-4-oxazolecarboxylic acid ethyl ester | C12H10ClNO3 |
| 127919-28-2 | Ethyl 5-(4-chlorophenyl)oxazole-4-carboxylate | C12H10ClNO3 |
| 127919-29-3 | 5-(2-Fluorophenyl)-4-oxazolecarboxylic acid ethyl ester | C12H10FNO3 |
| 127919-31-7 | Ethyl 5-(4-fluorophenyl)oxazole-4-carboxylate | C12H10FNO3 |
| 127923-87-9 | Rifapentine hydrochloride | C47H64N4O12.HCl |
| 127926-65-2 | 9,9-Bis(3-fluoro-4-aminophenyl)fluorene | C25H18F2N2 |
| 127942-30-7 | Ethyl 2-aminothiazole-4-carboxylate hydrobromide | C6H8N2O2S.HBr |
| 127946-77-4 | 1-Amino-1-cyclopropanecarbonitrile hydrochloride | C4H7ClN2 |
| 127947-26-6 | Siloxanes and Silicones, di-Me, mono[3-[(2-methyl-1-oxo-2-propen-1-yl)oxy]propyl group]-terminated | |
| 127955-44-6 | Erythromycin EP Impurity L | C37H65NO14 |
| 127958-06-9 | 4-Ethyl-2-methylpyrimidine-5-carboxylic acid | C8H10N2O2 |
| 127958-08-1 | 4-Isopropyl-2-methylpyrimidine-5-carboxylic acid | C9H12N2O2 |
| 127958-64-9 | Hexahydro-2H-1,4-benzoxazin-3(4H)-one | C8H13NO2 |
| 127959-06-2 / 478518-83-1 | 2-(Acetylamino)-2-deoxy-D-glucose labeled with carbon-13 | C8H15NO6 |
| 127970-62-1 | 3alpha-Carboxyacetoxy-24-methylene-23-oxolanost-8-en-26-oic acid | C34H50O7 |
| 127971-24-8 | 1-Cyclopropyl-4-bromonaphthalene | C13H11Br |
| 127972-00-3 | 2-Methoxy-5-methylphenylboronic acid | C8H11BO3 |